Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Feb 21. pii: S0272-6386(17)31129-0. doi: 10.1053/j.ajkd.2017.11.010. [Epub ahead of print]

PMID:
29475768
2.

Reproducibility of clinical research in critical care: a scoping review.

Niven DJ, McCormick TJ, Straus SE, Hemmelgarn BR, Jeffs L, Barnes TRM, Stelfox HT.

BMC Med. 2018 Feb 21;16(1):26. doi: 10.1186/s12916-018-1018-6.

3.
4.

Implementation and Evaluation of a Risk-Based Approach to Guide Chronic Kidney Disease Care: Protocol for a Multiphase Mixed-Methods Study.

Hemmelgarn BR, Smekal MD, Weaver RG, Thomas C, Benterud E, Tam K, Manns BJ, Tonelli M, Finlay J, Donald M, Tam-Tham H, Bello A, Tangri N, Quinn RR.

Can J Kidney Health Dis. 2018 Jan 17;5:2054358117753618. doi: 10.1177/2054358117753618. eCollection 2018.

5.

Proportion of women presenters at medical grand rounds at major academic centres in Canada: a retrospective observational study.

Buell D, Hemmelgarn BR, Straus SE.

BMJ Open. 2018 Jan 18;8(1):e019796. doi: 10.1136/bmjopen-2017-019796.

6.

Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N.

Clin J Am Soc Nephrol. 2018 Jan 15. pii: CJN.08510817. doi: 10.2215/CJN.08510817. [Epub ahead of print]

PMID:
29335321
7.

Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study.

Thompson S, Wiebe N, Klarenbach S, Pelletier R, Hemmelgarn BR, Gill JS, Manns BJ, Tonelli M; Alberta Kidney Disease Network.

BMC Nephrol. 2017 Dec 8;18(1):357. doi: 10.1186/s12882-017-0773-5.

8.

Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.

James MT, Pannu N, Hemmelgarn BR, Austin PC, Tan Z, McArthur E, Manns BJ, Tonelli M, Wald R, Quinn RR, Ravani P, Garg AX.

JAMA. 2017 Nov 14;318(18):1787-1797. doi: 10.1001/jama.2017.16326.

PMID:
29136443
9.

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

Jun M, Lix LM, Durand M, Dahl M, Paterson JM, Dormuth CR, Ernst P, Yao S, Renoux C, Tamim H, Wu C, Mahmud SM, Hemmelgarn BR; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

BMJ. 2017 Oct 17;359:j4323. doi: 10.1136/bmj.j4323.

10.

Disparity between Nephrologists' Opinions and Contemporary Practices for Community Follow-Up after AKI Hospitalization.

Karsanji DJ, Pannu N, Manns BJ, Hemmelgarn BR, Tan Z, Jindal K, Scott-Douglas N, James MT.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1753-1761. doi: 10.2215/CJN.01450217. Epub 2017 Oct 12.

PMID:
29025786
11.

The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial.

Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT.

Can J Diabetes. 2017 Dec;41(6):580-586. doi: 10.1016/j.jcjd.2017.08.244. Epub 2017 Sep 28.

PMID:
28965748
12.

Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled RxEACH Trial.

Al Hamarneh YN, Tsuyuki RT, Jones CA, Manns B, Tonelli M, Scott-Douglass N, Jindal K, Tink W, Hemmelgarn BR.

Am J Kidney Dis. 2018 Jan;71(1):42-51. doi: 10.1053/j.ajkd.2017.07.012. Epub 2017 Sep 12.

PMID:
28912054
13.

Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Nov;70(5):696-704. doi: 10.1053/j.ajkd.2017.06.029. Epub 2017 Aug 31.

PMID:
28838766
14.

Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.

Veroniki AA, Rios P, Cogo E, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C, Thavorn K, Hutton B, Hemmelgarn BR, Yazdi F, D'Souza J, MacDonald H, Tricco AC.

BMJ Open. 2017 Jul 20;7(7):e017248. doi: 10.1136/bmjopen-2017-017248.

15.

Trends in the Management of Patients With Kidney Failure in Alberta, Canada (2004-2013).

Chong CC, Tam-Tham H, Hemmelgarn BR, Weaver RG, Scott-Douglas N, Tonelli M, Quinn RR, Manns L, Manns BJ.

Can J Kidney Health Dis. 2017 Mar 22;4:2054358117698668. doi: 10.1177/2054358117698668. eCollection 2017.

16.

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.

Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C, Thavorn K, Hutton B, Hemmelgarn BR, Yazdi F, D'Souza J, MacDonald H, Tricco AC.

BMC Med. 2017 May 5;15(1):95. doi: 10.1186/s12916-017-0845-1.

17.

Barriers to care in patients with diabetes and poor glycemic control-A cross-sectional survey.

McBrien KA, Naugler C, Ivers N, Weaver RG, Campbell D, Desveaux L, Hemmelgarn BR, Edwards AL, Saad N, Nicholas D, Manns BJ.

PLoS One. 2017 May 1;12(5):e0176135. doi: 10.1371/journal.pone.0176135. eCollection 2017.

18.

In Reply to 'International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD'.

Jun M, Hemmelgarn BR.

Am J Kidney Dis. 2017 Jun;69(6):863-864. doi: 10.1053/j.ajkd.2017.02.368. Epub 2017 Apr 17. No abstract available.

PMID:
28427791
19.

Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study.

Donald M, King-Shier K, Tsuyuki RT, Al Hamarneh YN, Jones CA, Manns B, Tonelli M, Tink W, Scott-Douglas N, Hemmelgarn BR.

CMAJ Open. 2017 Mar 6;5(1):E205-E212. doi: 10.9778/cmajo.20160135. eCollection 2017 Jan-Mar.

20.

Cyclooxygenase-2 Inhibition Limits Angiotensin II-Induced DNA Oxidation and Protein Nitration in Humans.

Pialoux V, Poulin MJ, Hemmelgarn BR, Muruve DA, Chirico EN, Faes C, Sola DY, Ahmed SB.

Front Physiol. 2017 Mar 10;8:138. doi: 10.3389/fphys.2017.00138. eCollection 2017.

21.

Exploring the impact of financial barriers on secondary prevention of heart disease.

Dhaliwal KK, King-Shier K, Manns BJ, Hemmelgarn BR, Stone JA, Campbell DJ.

BMC Cardiovasc Disord. 2017 Feb 14;17(1):61. doi: 10.1186/s12872-017-0495-4.

22.

Financial barriers and adverse clinical outcomes among patients with cardiovascular-related chronic diseases: a cohort study.

Campbell DJ, Manns BJ, Weaver RG, Hemmelgarn BR, King-Shier KM, Sanmartin C.

BMC Med. 2017 Feb 15;15(1):33. doi: 10.1186/s12916-017-0788-6.

23.

The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death.

Quinn RR, Oliver MJ, Devoe D, Poinen K, Kabani R, Kamar F, Mysore P, Lewin AM, Hiremath S, MacRae J, James MT, Miller L, Hemmelgarn BR, Moist LM, Garg AX, Chowdhury TT, Ravani P.

J Am Soc Nephrol. 2017 Feb;28(2):613-620. doi: 10.1681/ASN.2016020151. Epub 2016 Oct 6.

24.

Emergency Department Use among Patients with CKD: A Population-Based Analysis.

Ronksley PE, Tonelli M, Manns BJ, Weaver RG, Thomas CM, MacRae JM, Ravani P, Quinn RR, James MT, Lewanczuk R, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):304-314. doi: 10.2215/CJN.06280616. Epub 2017 Jan 24.

25.

Sex differences in associations between insulin resistance, heart rate variability, and arterial stiffness in healthy women and men: a physiology study.

Rannelli LA, MacRae JM, Mann MC, Ramesh S, Hemmelgarn BR, Rabi D, Sola DY, Ahmed SB.

Can J Physiol Pharmacol. 2017 Apr;95(4):349-355. doi: 10.1139/cjpp-2016-0122. Epub 2016 Nov 2.

PMID:
28099042
26.

Chronic disease management interventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis.

Galbraith L, Jacobs C, Hemmelgarn BR, Donald M, Manns BJ, Jun M.

Nephrol Dial Transplant. 2018 Jan 1;33(1):112-121. doi: 10.1093/ndt/gfw359.

PMID:
28096482
27.

Use of Mixed Methods Research in Research on Coronary Artery Disease, Diabetes Mellitus, and Hypertension: A Scoping Review.

Campbell DJ, Tam-Tham H, Dhaliwal KK, Manns BJ, Hemmelgarn BR, Sanmartin C, King-Shier K.

Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). pii: e003310. doi: 10.1161/CIRCOUTCOMES.116.003310. Review.

28.

Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis.

Tricco AC, Blondal E, Veroniki AA, Soobiah C, Vafaei A, Ivory J, Strifler L, Cardoso R, Reynen E, Nincic V, Ashoor H, Ho J, Ng C, Johnson C, Lillie E, Antony J, Roberts DJ, Hemmelgarn BR, Straus SE.

BMC Med. 2016 Dec 23;14(1):216. doi: 10.1186/s12916-016-0761-9. Review.

29.

Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.

Jun M, James MT, Ma Z, Zhang J, Tonelli M, McAlister FA, Manns BJ, Ravani P, Quinn RR, Wiebe N, Perkovic V, Wilton SB, Winkelmayer WC, Hemmelgarn BR; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Jun;69(6):734-743. doi: 10.1053/j.ajkd.2016.10.018. Epub 2016 Dec 18.

PMID:
27998624
30.

Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease?

McAlister FA, Wiebe N, Jun M, Sandhu R, James MT, McMurtry MS, Hemmelgarn BR, Tonelli M.

Can J Cardiol. 2017 Feb;33(2):243-252. doi: 10.1016/j.cjca.2016.08.018. Epub 2016 Sep 30.

PMID:
27956042
31.

Prognostic implications of adding urine output to serum creatinine measurements for staging of acute kidney injury after major surgery: a cohort study.

Quan S, Pannu N, Wilson T, Ball C, Tan Z, Tonelli M, Hemmelgarn BR, Dixon E, James MT.

Nephrol Dial Transplant. 2016 Dec;31(12):2049-2056.

PMID:
27941063
32.

Finding resiliency in the face of financial barriers: Development of a conceptual framework for people with cardiovascular-related chronic disease.

Campbell DJ, Manns BJ, Leblanc P, Hemmelgarn BR, Sanmartin C, King-Shier K.

Medicine (Baltimore). 2016 Dec;95(49):e5561.

33.

Understanding Financial Barriers to Care in Patients With Diabetes.

Campbell DJ, Manns BJ, Hemmelgarn BR, Sanmartin C, Edwards A, King-Shier K.

Diabetes Educ. 2017 Feb;43(1):78-86. doi: 10.1177/0145721716679276. Epub 2016 Dec 7.

PMID:
27920081
34.

Digging Deeper: Hidden Messages Beyond the Overall Prevalence of Diabetic Kidney Disease.

Tam-Tham H, Campbell DJT, Hemmelgarn BR.

Am J Kidney Dis. 2017 Apr;69(4):495-497. doi: 10.1053/j.ajkd.2016.10.013. Epub 2016 Nov 23. No abstract available.

PMID:
27889298
35.

Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC, Wanner C, Kasiske BL, Wheeler DC, Groop PH; Conference Participants.

Kidney Int. 2016 Dec;90(6):1175-1183. doi: 10.1016/j.kint.2016.09.010.

36.

Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Jha V, Arici M, Collins AJ, Garcia-Garcia G, Hemmelgarn BR, Jafar TH, Pecoits-Filho R, Sola L, Swanepoel CR, Tchokhonelidze I, Wang AY, Kasiske BL, Wheeler DC, Spasovski G; Conference Participants.

Kidney Int. 2016 Dec;90(6):1164-1174. doi: 10.1016/j.kint.2016.09.009.

37.

Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension.

Rymkiewicz P, Ravani P, Hemmelgarn BR, McAlister FA, Southern DA, Walker R, Chen G, Quan H.

BMC Health Serv Res. 2016 Nov 22;16(1):671.

38.

A Clinical Risk Prediction Tool for 6-Month Mortality After Dialysis Initiation Among Older Adults.

Wick JP, Turin TC, Faris PD, MacRae JM, Weaver RG, Tonelli M, Manns BJ, Hemmelgarn BR.

Am J Kidney Dis. 2017 May;69(5):568-575. doi: 10.1053/j.ajkd.2016.08.035. Epub 2016 Nov 14.

PMID:
27856091
39.

Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.

Ronksley PE, Hemmelgarn BR, Manns BJ, Wick J, James MT, Ravani P, Quinn RR, Scott-Douglas N, Lewanczuk R, Tonelli M.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2022-2031. Epub 2016 Oct 6.

40.

Primary care physicians' perceived barriers, facilitators and strategies to enhance conservative care for older adults with chronic kidney disease: a qualitative descriptive study.

Tam-Tham H, Hemmelgarn BR, Campbell DJ, Thomas CM, Fruetel K, Quinn RR, King-Shier KM.

Nephrol Dial Transplant. 2016 Nov;31(11):1864-1870. Epub 2015 Dec 17.

PMID:
26681733
41.

Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials.

Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR, Manns BJ, Tonelli M; Alberta Kidney Disease Network.

CMAJ. 2017 Mar 6;189(9):E341-E364. doi: 10.1503/cmaj.150885. Epub 2016 Oct 31. Review.

42.

The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study.

McBrien KA, Manns BJ, Hemmelgarn BR, Weaver R, Edwards AL, Ivers N, Rabi D, Lewanczuk R, Braun T, Naugler C, Campbell D, Saad N, Tonelli M.

Diabet Med. 2016 Nov;33(11):1499-1507. doi: 10.1111/dme.13023. Epub 2015 Dec 6.

PMID:
26526088
43.

The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled Trial.

Mann MC, Exner DV, Hemmelgarn BR, Hanley DA, Turin TC, MacRae JM, Wheeler DC, Sola DY, Ramesh S, Ahmed SB.

Nutrients. 2016 Sep 28;8(10). pii: E608.

44.

Influence of Using Different Databases and 'Look Back' Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services Researchers.

Chen G, Lix L, Tu K, Hemmelgarn BR, Campbell NR, McAlister FA, Quan H; Hypertension Outcome and Surveillance Team.

PLoS One. 2016 Sep 1;11(9):e0162074. doi: 10.1371/journal.pone.0162074. eCollection 2016.

45.

A randomized controlled trial comparing in-person and wiki-inspired nominal group techniques for engaging stakeholders in chronic kidney disease research prioritization.

Elliott MJ, Straus SE, Pannu N, Ahmed SB, Laupacis A, Chong GC, Hillier DR, Huffman KT, Lei AC, Villanueva BV, Young DM, Tam-Tham H, Donald M, Lillie E, Manns BJ, Hemmelgarn BR.

BMC Med Inform Decis Mak. 2016 Aug 24;16:113. doi: 10.1186/s12911-016-0351-y.

46.

Prevalence of Barriers and Facilitators to Enhancing Conservative Kidney Management for Older Adults in the Primary Care Setting.

Tam-Tham H, King-Shier KM, Thomas CM, Quinn RR, Fruetel K, Davison SN, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2012-2021. Epub 2016 Aug 22.

47.

Development and implementation of an online clinical pathway for adult chronic kidney disease in primary care: a mixed methods study.

Donald M, McBrien K, Jackson W, Manns BJ, Tonelli M, King-Shier K, Jindal K, Lewanczuk RZ, Scott-Douglas N, Braun T, Straus SE, Naugler C, Elliott MJ, Jun M, Hemmelgarn BR.

BMC Med Inform Decis Mak. 2016 Aug 17;16:109. doi: 10.1186/s12911-016-0350-z.

48.

Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease.

Tong A, Samuel S, Zappitelli M, Dart A, Furth S, Eddy A, Groothoff J, Webb NJ, Yap HK, Bockenhauer D, Sinha A, Alexander SI, Goldstein SL, Gipson DS, Hanson CS, Evangelidis N, Crowe S, Harris T, Hemmelgarn BR, Manns B, Gill J, Tugwell P, Van Biesen W, Wheeler DC, Winkelmayer WC, Craig JC; SONG-Kids Investigators.

Trials. 2016 Aug 12;17:401. doi: 10.1186/s13063-016-1528-5. Review.

49.

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Hu N, Juurlink DN, Paterson JM, Targownik LE, Turin TC, Ernst P; and the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators, Suissa S, Dormuth CR, Hemmelgarn BR, Teare GF, Caetano P, Chateau D, Henry DA, Paterson JM, LeLorier J, Levy AR, Ernst P, Platt RW, Sketris IS.

JAMA Intern Med. 2016 Oct 1;176(10):1464-1473. doi: 10.1001/jamainternmed.2016.1522.

PMID:
27479930
50.

Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study.

James MT, Wilton SB, Clement FM, Ghali WA, Knudtson ML, Tan Z, Tonelli M, Hemmelgarn BR, Norris CM; Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) and Alberta Kidney Disease Network (AKDN) Investigators.

J Am Heart Assoc. 2016 Jul 19;5(7). pii: e003642. doi: 10.1161/JAHA.116.003642.

Supplemental Content

Loading ...
Support Center